Squarepoint’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.9M | Sell |
6,480
-56
| -0.9% | -$18.4K | ﹤0.01% | 2221 |
|
|
2025
Q4 | $2.29M | Sell |
6,536
-244,219
| -97% | -$82.5M | ﹤0.01% | 1968 |
|
|
2025
Q3 | $81M | Buy |
250,755
+88,396
| +54% | +$27.5M | 0.08% | 267 |
|
|
2025
Q2 | $63.2M | Sell |
162,359
-126,526
| -44% | -$50.9M | 0.07% | 330 |
|
|
2025
Q1 | $126M | Sell |
288,885
-299,035
| -51% | -$120M | 0.15% | 120 |
|
|
2024
Q4 | $217M | Buy |
587,920
+445,528
| +313% | +$186M | 0.21% | 58 |
|
|
2024
Q3 | $74M | Buy |
142,392
+136,093
| +2,161% | +$72.7M | 0.12% | 154 |
|
|
2024
Q2 | $3.41M | Sell |
6,299
-65,134
| -91% | -$34.4M | 0.01% | 1647 |
|
|
2024
Q1 | $37M | Sell |
71,433
-6,156
| -8% | -$3.06M | 0.06% | 358 |
|
|
2023
Q4 | $36.6M | Sell |
77,589
-53,208
| -41% | -$24.6M | 0.07% | 316 |
|
|
2023
Q3 | $57M | Sell |
130,797
-68,571
| -34% | -$31.1M | 0.14% | 143 |
|
|
2023
Q2 | $88.6M | Buy |
199,368
+123,157
| +162% | +$56.8M | 0.27% | 55 |
|
|
2023
Q1 | $35M | Sell |
76,211
-38,421
| -34% | -$18.3M | 0.14% | 139 |
|
|
2022
Q4 | $58.8M | Sell |
114,632
-5,556
| -5% | -$2.82M | 0.23% | 71 |
|
|
2022
Q3 | $54.6M | Buy |
120,188
+37,302
| +45% | +$17.8M | 0.28% | 58 |
|
|
2022
Q2 | $40M | Buy |
+82,886
| New | +$41M | 0.22% | 79 |
|
|
2022
Q1 | – | Sell |
-6,894
| Closed | -$3.15M | – | 3014 |
|
|
2021
Q4 | $3.2M | Sell |
6,894
-12,363
| -64% | -$5.2M | 0.01% | 996 |
|
|
2021
Q3 | $7.18M | Sell |
19,257
-17,263
| -47% | -$6.56M | 0.02% | 626 |
|
|
2021
Q2 | $13.9M | Buy |
36,520
+31,304
| +600% | +$12M | 0.05% | 342 |
|
|
2021
Q1 | $1.87M | Sell |
5,216
-4,897
| -48% | -$1.57M | 0.01% | 1112 |
|
|
2020
Q4 | $3.25M | Sell |
10,113
-13,328
| -57% | -$4.09M | 0.02% | 669 |
|
|
2020
Q3 | $6.3M | Sell |
23,441
-31,666
| -57% | -$8.52M | 0.08% | 285 |
|
|
2020
Q2 | $14.5M | Buy |
55,107
+42,428
| +335% | +$11.3M | 0.23% | 101 |
|
|
2020
Q1 | $2.88M | Sell |
12,679
-71,483
| -85% | -$19.5M | 0.07% | 348 |
|
|
2019
Q4 | $25.4M | Sell |
84,162
-96,995
| -54% | -$26.7M | 0.15% | 112 |
|
|
2019
Q3 | $43.5M | Buy |
181,157
+177,657
| +5,076% | +$48.7M | 0.39% | 38 |
|
|
2019
Q2 | $988K | Sell |
3,500
-39,748
| -92% | -$10.9M | 0.01% | 1266 |
|
|
2019
Q1 | $12.4M | Buy |
+43,248
| New | +$12.5M | 0.13% | 183 |
|
|
2018
Q4 | – | Sell |
-43,678
| Closed | -$12M | – | 2014 |
|
|
2018
Q3 | $12M | Buy |
43,678
+4,460
| +11% | +$1.16M | 0.14% | 188 |
|
|
2018
Q2 | $9.34M | Buy |
39,218
+11,158
| +40% | +$2.58M | 0.12% | 246 |
|
|
2018
Q1 | $6.17M | Sell |
28,060
-28,181
| -50% | -$6.62M | 0.1% | 265 |
|
|
2017
Q4 | $12.7M | Buy |
56,241
+21,634
| +63% | +$4.61M | 0.22% | 90 |
|
|
2017
Q3 | $6.57M | Sell |
34,607
-14,858
| -30% | -$2.83M | 0.13% | 209 |
|
|
2017
Q2 | $9.31M | Buy |
+49,465
| New | +$8.89M | 0.18% | 128 |
|
|
2016
Q4 | – | Sell |
-19,616
| Closed | -$2.46M | – | 1803 |
|
|
2016
Q3 | $2.46M | Buy |
19,616
+11,475
| +141% | +$1.48M | 0.16% | 149 |
|
|
2016
Q2 | $1.07M | Sell |
8,141
-6,328
| -44% | -$866K | 0.07% | 328 |
|
|
2016
Q1 | $2.01M | Buy |
14,469
+5,830
| +67% | +$779K | 0.16% | 171 |
|
|
2015
Q4 | $1.21M | Sell |
8,639
-2,113
| -20% | -$291K | 0.13% | 215 |
|
|
2015
Q3 | $1.5M | Buy |
10,752
+6,401
| +147% | +$962K | 0.38% | 77 |
|
|
2015
Q2 | $714K | Buy |
+4,351
| New | +$695K | 0.23% | 138 |
|
Other funds holding ELV
VCM
VPM
Squarepoint's ELV Position: Q1 2026 in Review
Squarepoint reduced its Elevance Health (ELV) stake by 0.86% in Q1 2026, selling an estimated $18.4K and leaving 6,480 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2221.
Squarepoint first reported a position in ELV in Q2 2015 and has held it in 40 quarters since. The position peaked at $217M in Q4 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Squarepoint held 6,480 shares of Elevance Health worth $1.9M as of Q1 2026.
- Squarepoint sold 56 Elevance Health shares in Q1 2026, an estimated $18.4K.
- Elevance Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2221 holding.
- Squarepoint first reported a position in Elevance Health in Q2 2015 and has held it in 40 quarters since.
- Squarepoint's Elevance Health position peaked at $217M in Q4 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.